Appendix 2—table 18. “Bone-Rx” Cohort (Region=Northeast), Patient Characteristics Pre/Post Match.
| "Bone-Rx" Cohort / Region=Northeast Unmatched | "Bone-Rx" Cohort / Region=Northeast Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 135,867 | 100.0% | 16,139 | 11.9% | 119,728 | 88.1% | 31,986 | 100.0% | 15,993 | 50.0% | 15,993 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 245 | 0.2% | ≤10 | 0.1% | 236 | 0.2% | <0.001 | 15 | 0.0% | ≤10 | 0.1% | ≤10 | 0.0% | 0.99 |
| 21-40 | 891 | 0.7% | 127 | 0.8% | 764 | 0.6% | 250 | 0.8% | 124 | 0.8% | 126 | 0.8% | ||
| 41-50 | 2,340 | 1.7% | 298 | 1.8% | 2,042 | 1.7% | 570 | 1.8% | 290 | 1.8% | 280 | 1.8% | ||
| 51-60 | 20,069 | 14.8% | 2,059 | 12.8% | 18,010 | 15.0% | 4,088 | 12.8% | 2,049 | 12.8% | 2,039 | 12.7% | ||
| 61-70 | 45,896 | 33.8% | 4,802 | 29.8% | 41,094 | 34.3% | 9,526 | 29.8% | 4,767 | 29.8% | 4,759 | 29.8% | ||
| 71-80 | 42,828 | 31.5% | 5,267 | 32.6% | 37,561 | 31.4% | 10,465 | 32.7% | 5,226 | 32.7% | 5,239 | 32.8% | ||
| ≥81 | 23,598 | 17.4% | 3,577 | 22.2% | 20,021 | 16.7% | 7,072 | 22.1% | 3,528 | 22.1% | 3,544 | 22.2% | ||
| Gender | ||||||||||||||
| Female | 122,485 | 90.2% | 14,115 | 87.5% | 108,370 | 90.5% | <0.001 | 28,157 | 88.0% | 14,062 | 87.9% | 14,095 | 88.1% | 0.57 |
| Male | 13,382 | 9.8% | 2,024 | 12.5% | 11,358 | 9.5% | 3,829 | 12.0% | 1,931 | 12.1% | 1,898 | 11.9% | ||
| Insurance | ||||||||||||||
| Commercial | 37,810 | 27.8% | 4,517 | 28.0% | 33,293 | 27.8% | <0.001 | 8,927 | 27.9% | 4,459 | 27.9% | 4,468 | 27.9% | 0.99 |
| Dual | 8,434 | 6.2% | 829 | 5.1% | 7,605 | 6.4% | 1,637 | 5.1% | 824 | 5.2% | 813 | 5.1% | ||
| Medicaid | 25,296 | 18.6% | 2,082 | 12.9% | 23,214 | 19.4% | 4,122 | 12.9% | 2,067 | 12.9% | 2,055 | 12.8% | ||
| Medicare | 64,327 | 47.3% | 8,711 | 54.0% | 55,616 | 46.5% | 17,300 | 54.1% | 8,643 | 54.0% | 8,657 | 54.1% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 56,593 | 41.7% | 6,726 | 41.7% | 49,867 | 41.7% | 0.95 | 13,307 | 41.6% | 6,654 | 41.6% | 6,653 | 41.6% | 0.99 |
| Yes | 79,274 | 58.3% | 9,413 | 58.3% | 69,861 | 58.3% | 18,679 | 58.4% | 9,339 | 58.4% | 9,340 | 58.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.06 | 1.89 | 1.97 | 2.70 | 0.93 | 1.71 | <0.001 | 1.89 | 2.57 | 1.89 | 2.58 | 1.89 | 2.57 | 0.91 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.